Published in Int J Cancer on August 15, 1989
Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) (2005) 0.98
Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. Mol Pathol (2001) 0.82
The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology (1999) 1.74
Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology (2001) 1.53
Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol (1991) 1.46
A morphometric study of liver cell dysplasia. Hum Pathol (1988) 1.40
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood (1991) 1.23
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology (1995) 1.17
Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.14
Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood (1991) 1.11
Laparoscopic choledochotomy with primary closure. Follow-up (5-44 months) of 31 patients. Surg Endosc (1996) 1.09
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol (2001) 1.09
Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol (1994) 1.09
Immunophenotypic analysis of the transformation zone of human cervix. Lab Invest (1988) 1.08
Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up. Hepatology (2000) 1.07
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology (1999) 1.00
Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology (1995) 0.97
Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study. Cancer (1986) 0.96
Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat (2004) 0.96
Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. Gut (1983) 0.94
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem (1999) 0.94
Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver (1994) 0.92
Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology (2000) 0.92
Enumeration of absolute cell counts using immunophenotypic techniques. Curr Protoc Cytom (2001) 0.89
Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype. Eur J Gastroenterol Hepatol (2001) 0.88
Metabolic effects of chronic prazosin treatment. Horm Metab Res (1980) 0.88
The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis. J Hepatol (1994) 0.86
Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology (1999) 0.86
Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines. Leuk Res (2007) 0.85
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. J Hepatol (1998) 0.83
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans. Cancer Res (1989) 0.82
Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy. Infection (2012) 0.81
A multicenter, prospective study of posttransfusion hepatitis in Milan. Hepatology (1987) 0.81
The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation (1997) 0.81
Effect of familial hypertension on glomerular hemodynamics and tubulo-glomerular feedback after uninephrectomy. Am J Hypertens (2001) 0.81
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Mol Pathol (1998) 0.80
Liver-cell dysplasia and hepatocellular carcinoma. Ital J Gastroenterol (1992) 0.80
CD90. J Biol Regul Homeost Agents (2001) 0.79
Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction. Acta Endocrinol (Copenh) (1981) 0.79
Effect of loperamide, a peripheral opiate agonist, on circulating glucose, free fatty acids, insulin, C-peptide and pituitary hormones in healthy man. Eur J Clin Pharmacol (1981) 0.79
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies. Haematologica (1992) 0.78
Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol Suppl (1993) 0.77
Panleucogating as an accurate and affordable flow cytometric protocol to analyse lymphocyte subsets among HIV-positive patients on HAART treatment in Mozambique. J Biol Regul Homeost Agents (2006) 0.77
The role of donor and recipient factors in initial renal graft non-function. Transplant Proc (1988) 0.77
Increment of nonreceptor tyrosine kinase Arg RNA as evaluated by semiquantitative RT-PCR in granulocyte and macrophage-like differentiation of HL-60 cells. Exp Cell Res (1998) 0.77
Immunophenotyping of mononuclear cell infiltrates associated with renal disease. Clin Nephrol (1986) 0.77
Preneoplastic cellular changes in liver. Hepatology (1998) 0.77
Relationship between sodium intake, proximal tubular function and calcium excretion in normal subjects and in idiopathic hypercalciuria. Proc Eur Dial Transplant Assoc (1983) 0.77
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients. Haematologica (1991) 0.77
Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs. Transplant Proc (1998) 0.77
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H. Leukemia (2004) 0.77
Diagnostic and prognostic value of flow cytometric immunophenotyping in malignant hematological diseases. J Biol Regul Homeost Agents (2003) 0.77
Liver cell dysplasia and hepatocellular carcinoma: a histological and immunohistochemical study. Histopathology (1985) 0.76
Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study. J Nephrol (1998) 0.76
Epidemiology and outcome of hepatocellular carcinoma in Lombardy. Dig Liver Dis (2007) 0.76
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease. Am J Gastroenterol (1999) 0.76
Breakthrough of interferon therapy. Am J Gastroenterol (1996) 0.75
Comprehensive allelotype study of hepatocellular carcinoma. Hepatology (2000) 0.75
Occurrence of Kaposi's sarcoma in renal transplant recipients treated with low doses of cyclosporine. Transplant Proc (1988) 0.75
Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man. Gut (1985) 0.75
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft. J Biol Regul Homeost Agents (1989) 0.75
Interferon-alpha in chronic hepatitis C. Ann Intern Med (1998) 0.75
Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G. J Hepatol (1997) 0.75
HCV genotypes and breakthrough in patients treated with recombinant alpha interferon. Am J Gastroenterol (1998) 0.75
Hepatocyte AgNOR protein quantitative expression is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Eur J Histochem (1997) 0.75
Granulomatous and nongranulomatous lymphadenitis in sarcoidosis. An immunophenotypic study of seven cases. Pathol Res Pract (1989) 0.75
[Epidemiologic study of diabetic dyslipidemia]. Minerva Dietol Gastroenterol (1985) 0.75
Hepatocellular carcinoma in cirrhotic patients: role of hepatitis B virus. Ital J Gastroenterol (1990) 0.75
Prolactin and growth hormone responses to the serotonin antagonist, metergoline, in liver cirrhosis: further evidence for serotoninergic dysfunction. Horm Metab Res (1982) 0.75
[Pulmonary sarcoid-like necrotizing granulomatosis]. Recenti Prog Med (1983) 0.75
[Treatment with high doses of progestational agents in endometrial adenocarcinoma]. Minerva Ginecol (1976) 0.75
[Experimental studies of pulmonary changes induced by administration of bleomycin in the rat: preliminary report (proceedings)]. Radiol Med (1977) 0.75
Extra and intracranial meningiomas. Tumori (1980) 0.75
T-active rosette forming cells as a better index of kidney transplantation recipients' immune reactivity. Proc Eur Dial Transplant Assoc (1980) 0.75
[Diagnostic problems in spontaneous bacterial peritonitis]. Minerva Med (1986) 0.75
[Renal failure caused by renal angiomyolipoma . 2 cases of which one is a pregnancy at term]. Minerva Nefrol (1981) 0.75
[Intravascular endothelial papillary hyperplasia]. Pathologica (1982) 0.75
[The topical therapy of ulcerative colitis. A multicenter study with beclomethasone dipropionate foam]. Minerva Chir (1999) 0.75
Acute myelofibrosis developing into acute monocytic leukemia. A case report. Panminerva Med (1984) 0.75
["So-called" sclerosing hemangioma of the lung]. Pathologica (1986) 0.75
Immediate hypersensitivity gastropathy and duodenogastric reflux. Scand J Gastroenterol Suppl (1981) 0.75
Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis? Am J Gastroenterol (2000) 0.75
Effects of naloxone administration on pituitary hormones in cirrhotic patients. Horm Metab Res (1983) 0.75
[E-active rosette forming T lymphocytes in the kidney transplant. Significance of serial monitoring]. Minerva Nefrol (1981) 0.75
[Pulmonary pathology due to drugs. Experimental and clinical study of pulmonary changes induced by bleomycin]. G Ital Chemioter (1979) 0.75
Preliminary results of a two-center trial with colchicine for the treatment of chronic hepatitis B. Am J Gastroenterol (2001) 0.75
[Pseudoaldosteronism caused by licorice. Review of the literature and description of 4 clinical cases]. Minerva Med (1987) 0.75
Cytology of yolk-sac tumor of the ovary in ascitic fluid. Report of a case. Acta Cytol (1988) 0.75
[A case of intestinal schistosomiasis with hepatic involvement: interdisciplinary diagnostic approach and peculiarity of the echographic and histologic findings]. Recenti Prog Med (1989) 0.75
[Role of surgical therapy in the treatment of refractory ascites]. Minerva Chir (1997) 0.75
[Significance of the changes on amylase in the blood in acute radiation-induced sialadenitis and in post-irradiation sialadeno-fibrosis]. Quad Sclavo Diagn (1971) 0.75
[Therapeutic aspects of alcoholism in a medical department. II]. Clin Ter (1980) 0.75
Mixed Schistosoma infection in an asymptomatic patient. Boll Ist Sieroter Milan (1985) 0.75
[Diagnostic contribution of echography in a case of schistosomiasis]. Radiol Med (1989) 0.75